NASDAQ:ABUS - Arbutus Biopharma News Headlines

Sign in or create an account to add this stock to your watchlist.
$11.55 +0.15 (+1.32 %)
(As of 07/20/2018 02:13 PM ET)
Previous Close$11.50
Today's Range$11.45 - $11.95
52-Week Range$3.20 - $12.05
Volume15,406 shs
Average Volume833,219 shs
Market Capitalization$623.40 million
P/E Ratio-6.37
Dividend YieldN/A
Beta0.99

Headlines

Arbutus Biopharma (NASDAQ ABUS) News Headlines

Source:
DateHeadline
Arbutus to Report Second Quarter 2018 Financial ResultsArbutus to Report Second Quarter 2018 Financial Results
globenewswire.com - July 19 at 4:45 PM
Opinion: Harry Boxers three drug stocks to watchOpinion: Harry Boxer's three drug stocks to watch
www.marketwatch.com - July 19 at 4:45 PM
Arbutus: An Extremely Promising RNAi Innovator Hitting Its Growth InflectionArbutus: An Extremely Promising RNAi Innovator Hitting Its Growth Inflection
seekingalpha.com - July 19 at 8:15 AM
Arbutus Biopharma: Long-Term Growth Prospect Flying Too Close To The SunArbutus Biopharma: Long-Term Growth Prospect Flying Too Close To The Sun
seekingalpha.com - July 18 at 4:52 PM
Arbutus Biopharmas (ABUS) "Buy" Rating Reaffirmed at Chardan CapitalArbutus Biopharma's (ABUS) "Buy" Rating Reaffirmed at Chardan Capital
www.americanbankingnews.com - July 16 at 9:54 AM
Arbutus Biopharma Corp (ABUS) Given Consensus Recommendation of "Buy" by BrokeragesArbutus Biopharma Corp (ABUS) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 15 at 9:48 AM
Short Interest in Arbutus Biopharma Corp (ABUS) Rises By 281.0%Short Interest in Arbutus Biopharma Corp (ABUS) Rises By 281.0%
www.americanbankingnews.com - July 15 at 1:32 AM
Arbutus Biopharma Corp (ABUS) Insider Sells $100,000.00 in StockArbutus Biopharma Corp (ABUS) Insider Sells $100,000.00 in Stock
www.americanbankingnews.com - July 14 at 5:42 PM
Insider Selling: Arbutus Biopharma Corp (ABUS) Insider Sells 10,000 Shares of StockInsider Selling: Arbutus Biopharma Corp (ABUS) Insider Sells 10,000 Shares of Stock
www.americanbankingnews.com - July 10 at 3:14 PM
Arbutus Presents Corporate Update on Key MilestonesArbutus Presents Corporate Update on Key Milestones
finance.yahoo.com - July 10 at 8:16 AM
Michael J. Sofia Sells 10,000 Shares of Arbutus Biopharma Corp (ABUS) StockMichael J. Sofia Sells 10,000 Shares of Arbutus Biopharma Corp (ABUS) Stock
www.americanbankingnews.com - July 6 at 6:32 PM
Arbutus Biopharma Corp (ABUS) Insider Michael J. Sofia Sells 20,000 SharesArbutus Biopharma Corp (ABUS) Insider Michael J. Sofia Sells 20,000 Shares
www.americanbankingnews.com - July 6 at 6:32 PM
B.Riley/FBR Downgrades Arbutus Biopharma (ABUS) to NeutralB.Riley/FBR Downgrades Arbutus Biopharma (ABUS) to Neutral
www.streetinsider.com - July 6 at 8:15 AM
B. Riley Downgrades Arbutus Biopharma (ABUS) to NeutralB. Riley Downgrades Arbutus Biopharma (ABUS) to Neutral
www.americanbankingnews.com - July 6 at 7:58 AM
Arbutus Biopharma (ABUS) Expected to Post Earnings of -$0.35 Per ShareArbutus Biopharma (ABUS) Expected to Post Earnings of -$0.35 Per Share
www.americanbankingnews.com - July 4 at 4:30 AM
Form 4 Arbutus Biopharma Corp For: Jun 19 Filed by: HENRIQUES RICHARD C JRForm 4 Arbutus Biopharma Corp For: Jun 19 Filed by: HENRIQUES RICHARD C JR
www.streetinsider.com - June 27 at 8:57 AM
Arbutus Biopharma: The Next Big Breakout Biotech?Arbutus Biopharma: The Next Big Breakout Biotech?
seekingalpha.com - June 22 at 5:42 PM
B. Riley Weighs in on Arbutus Biopharmas FY2021 Earnings (ABUS)B. Riley Weighs in on Arbutus Biopharma's FY2021 Earnings (ABUS)
www.americanbankingnews.com - June 20 at 7:47 AM
Arbutus Biopharma (ABUS) Given Average Rating of "Buy" by BrokeragesArbutus Biopharma (ABUS) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - June 19 at 1:43 PM
Arbutus Biopharma to Present at First Annual Roivant Pipeline DayArbutus Biopharma to Present at First Annual Roivant Pipeline Day
finance.yahoo.com - June 18 at 8:50 AM
Arbutus Biopharma (ABUS) Expected to Announce Earnings of -$0.35 Per ShareArbutus Biopharma (ABUS) Expected to Announce Earnings of -$0.35 Per Share
www.americanbankingnews.com - June 16 at 9:20 PM
Arbutus appoints David C. Hastings as new Chief Financial OfficerArbutus appoints David C. Hastings as new Chief Financial Officer
seekingalpha.com - June 8 at 8:17 AM
Arbutus Biopharma (ABUS) Announces Appointment of David C. Hastings as New Chief Financial OfficerArbutus Biopharma (ABUS) Announces Appointment of David C. Hastings as New Chief Financial Officer
www.streetinsider.com - June 8 at 8:17 AM
-$0.35 Earnings Per Share Expected for Arbutus Biopharma (ABUS) This Quarter-$0.35 Earnings Per Share Expected for Arbutus Biopharma (ABUS) This Quarter
www.americanbankingnews.com - May 30 at 11:18 AM
Arbutus Biopharma (ABUS) Given Consensus Recommendation of "Buy" by AnalystsArbutus Biopharma (ABUS) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - May 25 at 1:40 PM
Arbutus Biopharma (ABUS) Upgraded at BidaskClubArbutus Biopharma (ABUS) Upgraded at BidaskClub
www.americanbankingnews.com - May 16 at 4:50 PM
Zacks: Brokerages Anticipate Arbutus Biopharma (ABUS) Will Post Earnings of -$0.35 Per ShareZacks: Brokerages Anticipate Arbutus Biopharma (ABUS) Will Post Earnings of -$0.35 Per Share
www.americanbankingnews.com - May 13 at 10:40 AM
Q2 2018 EPS Estimates for Arbutus Biopharma (ABUS) Decreased by WedbushQ2 2018 EPS Estimates for Arbutus Biopharma (ABUS) Decreased by Wedbush
www.americanbankingnews.com - May 10 at 7:16 AM
Arbutus Biopharmas (ABUS) Buy Rating Reaffirmed at Chardan CapitalArbutus Biopharma's (ABUS) Buy Rating Reaffirmed at Chardan Capital
www.americanbankingnews.com - May 7 at 11:27 AM
Arbutus Biopharmas (ABUS) CEO Mark Murray on Q1 2018 Results - Earnings Call TranscriptArbutus Biopharma's (ABUS) CEO Mark Murray on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 6 at 7:42 PM
Arbutus Biopharma (ABUS) Lifted to Buy at BidaskClubArbutus Biopharma (ABUS) Lifted to Buy at BidaskClub
www.americanbankingnews.com - May 5 at 12:29 AM
Arbutus Biopharma (ABUS) Reports Q1 Loss of $0.36/ShareArbutus Biopharma (ABUS) Reports Q1 Loss of $0.36/Share
www.streetinsider.com - May 4 at 5:34 PM
Arbutus Biopharma (ABUS) Issues Quarterly  Earnings ResultsArbutus Biopharma (ABUS) Issues Quarterly Earnings Results
www.americanbankingnews.com - May 4 at 4:36 PM
BRIEF-Arbutus Reports Q1 Loss Per Share $0.36BRIEF-Arbutus Reports Q1 Loss Per Share $0.36
www.reuters.com - May 4 at 8:18 AM
Arbutus: 1Q Earnings SnapshotArbutus: 1Q Earnings Snapshot
finance.yahoo.com - May 4 at 8:18 AM
Arbutus Biopharma beats by $0.03, beats on revenueArbutus Biopharma beats by $0.03, beats on revenue
seekingalpha.com - May 3 at 5:25 PM
Arbutus Announces Corporate Update and First Quarter 2018 Financial ResultsArbutus Announces Corporate Update and First Quarter 2018 Financial Results
finance.yahoo.com - May 3 at 5:25 PM
Merck Teams With Moderna To Take On One Of The Toughest Targets In CancerMerck Teams With Moderna To Take On One Of The Toughest Targets In Cancer
finance.yahoo.com - May 3 at 5:25 PM
Arbutus Biopharma (ABUS) Upgraded at ValuEngineArbutus Biopharma (ABUS) Upgraded at ValuEngine
www.americanbankingnews.com - May 2 at 11:41 PM
Arbutus Announces Conference Call to Provide a Corporate Update and First Quarter 2018 Financial ResultsArbutus Announces Conference Call to Provide a Corporate Update and First Quarter 2018 Financial Results
finance.yahoo.com - April 30 at 5:14 PM
Arbutus Biopharma (ABUS) Given Consensus Recommendation of "Buy" by BrokeragesArbutus Biopharma (ABUS) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 30 at 1:36 PM
Zacks: Analysts Expect Arbutus Biopharma (ABUS) to Announce -$0.38 EPSZacks: Analysts Expect Arbutus Biopharma (ABUS) to Announce -$0.38 EPS
www.americanbankingnews.com - April 25 at 11:10 PM
Arbutus Biopharma (ABUS) to Release Quarterly Earnings on WednesdayArbutus Biopharma (ABUS) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 25 at 7:33 AM
Arbutus Biopharma (ABUS) Upgraded to "Hold" by BidaskClubArbutus Biopharma (ABUS) Upgraded to "Hold" by BidaskClub
www.americanbankingnews.com - April 25 at 12:58 AM
Arbutus Biopharma (ABUS) Downgraded by Zacks Investment ResearchArbutus Biopharma (ABUS) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 19 at 10:12 PM
BRIEF-Arbutus And Roivant Launch Genevant Sciences With Platform To Develop Broad Range Of RNA Therapeutics ...BRIEF-Arbutus And Roivant Launch Genevant Sciences With Platform To Develop Broad Range Of RNA Therapeutics ...
www.reuters.com - April 13 at 5:33 PM
Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA ...Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA ...
globenewswire.com - April 13 at 5:33 PM
Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at ...Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at ...
globenewswire.com - April 13 at 5:33 PM
Form 8-K Arbutus Biopharma Corp For: Apr 12Form 8-K Arbutus Biopharma Corp For: Apr 12
www.streetinsider.com - April 13 at 5:33 PM
Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at EASL 2018Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at EASL 2018
finance.yahoo.com - April 12 at 5:39 PM
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Featured Article: What does EPS mean?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.